Walgreens Stock Jumps as Sales Grow, Adjusted Earnings Surpass Estimates
Shares of Walgreens Boots Alliance (WBA) rose Friday morning after the pharmacy retailer reported first-quarter results that included better revenue and adjusted profits than analysts had expected.
Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
The charts, the sell-side activity, and the outlook for a rebound have Walgreens Boots Alliance NASDAQ: WBA stock tracking for a rebound that will likely begin this year. Trading at only 6x earnings, this high-yielding deep-value has headwinds to bear and hurdles to cross, but there is nowhere for its stock price to go but up.
Walgreens' stock jumps 10% as troubled drugstore chain shows ‘early progress' with turnaround
Walgreens Boots Alliance Inc.'s stock jumped 10% early Friday after the troubled drugstore chain posted another loss but blew past estimates on an adjusted basis and said it would continue to work on a turnaround.
Walgreens Stock Pops After a Strong Quarter. What the CEO Says Went Right.
The retail pharmacy chain easily beats quarterly estimates for earnings and sales.
Walgreens Boots tops profit estimates as CEO's revamp efforts take hold
Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter profit and maintained its annual forecast on Friday, as the healthcare company benefits from CEO Tim Wentworth's efforts to turn around its business.
Walgreens Reports $265 Million Loss And Sees Progress On Turnaround
Walgreens Boots Alliance Friday reported a $265 million quarterly loss despite what the company chief executive said was “early progress” en route to a company turnaround that he says will “take time.”
Walgreens results top estimates as drugstore chain works to slash costs
Walgreens reported fiscal first-quarter earnings and revenue that topped expectations, as it shutters stores and cuts other costs to steer itself out of a rough spot. The company capped off a rocky 2024 marked by pharmacy reimbursement pressure, softer consumer spending and challenges related to its push into primary care, among other issues.
What Analysts Think of Walgreens Stock Ahead of Earnings
Walgreens Boots Alliance (WBA) is set to report fiscal first-quarter earnings before the opening bell Friday, with the pharmacy retailer coming off a year in which it was the worst-performing stock in the S&P 500.
Walgreens Could Have Reached Its Bottom, But Caution Is Still Advised
Walgreens Boots Alliance has seen a significant decline in stock price, with my position down 75%, leading me to reaffirm my "Hold" rating. WBA's dividend yield is 10.5%, but sustainability is questionable due to negative free cash flow and significant debt levels. Walgreens' recent financial results show increasing sales but worsening operating losses and net losses, with future growth expectations being modest.
Should Walgreens Stock Be in Your Portfolio Before Q1 Earnings?
WBA's fiscal 2025 first-quarter results are expected to continue to reflect a soft U.S. Retail Pharmacy performance.
Why Is Walgreens' Dividend Yield So High?
Walgreens (WBA -0.32%) is one of America's most recognizable drugstore brands. Up until this year, it has been a very dependable dividend-paying stock that increased its payout for investors annually for nearly 50 years, which would have distinguished it as a Dividend King.
Exploring Analyst Estimates for Walgreens (WBA) Q1 Earnings, Beyond Revenue and EPS
Get a deeper insight into the potential performance of Walgreens (WBA) for the quarter ended November 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
